PerkinElmer, Inc. announced the appointment of James M. Mock to senior vice president and chief financial officer (CFO), effective May 1, 2018. Andy Wilson, PerkinElmer’s current senior vice president and CFO, who previously announced his retirement from PerkinElmer, will remain with the Co ... more
PerkinElmer Acquires Analytica of Branford, Inc.Investment Enhances Mass Spectrometry Portfolio & Expertise
PerkinElmer, Inc. has acquired Analytica of Branford, Inc. The acquisition is an integral part of PerkinElmer's strategic commitment to continue to grow its human and environmental health portfolio. Terms of the acquisition were not disclosed.
With the completion of this acquisition, PerkinElmer will gain significant insight and intellectual property in the field of MS and ion source technology.
"Mass spectrometry has proven to be an essential tool in many fields and will continue to be of critical importance. Bringing Analytica's technology and team of highly innovative experts in-house will dramatically increase our capabilities in this area," said Richard Begley, Ph.D., president, Analytical Sciences, PerkinElmer. "The acquisition of Analytica will allow us to offer our customers access to critical technologies such as time-of-flight and quadrupole mass spectrometers and new ion sources that provide more complete information as well as better throughput."
Analytica's advanced technology complements PerkinElmer's human and environmental health portfolio. For human health applications, mass spectrometry provides an extremely detailed profile of medically relevant materials in drug discovery and molecular diagnostics. This technology is also the cornerstone of environmental detection and analysis and industrial monitoring. Areas of applications include environmental analysis, pharmaceutical and nutraceutical materials analysis, forensics and food safety.
PerkinElmer will integrate Analytica's current manufacturing operations into its Shelton, CT facility, while utilizing Analytica's existing Branford facility for R&D projects. Craig Whitehouse, founder and former president of Analytica, will become an employee of PerkinElmer and oversee PerkinElmer's MS R&D operations.
PerkinElmer, Inc. announced that it has entered into a definitive agreement to acquireEUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN. The total purchase price of the transaction based on all outstanding share ... more
PerkinElmer announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation. PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that serve as components for industrial, medical and de ... more
Global regulatory requirements are expanding – and analytical lab requirements are too. That is why we deliver innovative technologies that enable safer food, quality products, and a clean environment. Our latest innovation? An exceptional solution for a wide range of applications; food saf ... more
Designed to meet the most challenging of customer needs – and exceed them – the Avio 200 ICP allows you to run more samples more cost efficiently than ever before with an array of unique and proprietary features. Unique hardware features and the industry’s most intuitive software combine to ... more
PerkinElmer’s PinAAcle 500 is a robust, fully-integrated, flame-only benchtop system, ideal for laboratories needing a reliable, easy-to-use, yet high-performance flame AA. It is equipped with an innovative touchscreen interface with the flexibility to operate via its easy-to-use Syngistix ... more
PerkinElmer, Inc. has acquired Analytica of Branford, Inc. The acquisition is an integral part of PerkinElmer's strategic commitment to continue to grow its human and environmental health portfolio. Terms of the acquisition were not disclosed. With the completion of this acquisition, Perki ... more
- Bruker acquires pioneering IR company
- Detection of little-known flame retardant in the environment
- Technology measures tumors' drug resistance up to 10 times faster
- Lack of sleep may be linked to risk factor for Alzheimer's disease
- 'Scaffolding' method allows biochemists to see proteins in remarkable detail